Literature DB >> 12651978

Metformin-associated lactic acidosis in a patient with liver disease.

C M B Edwards, M A Barton, J Snook, M David, V H F Mak, T A Chowdhury.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12651978     DOI： 10.1093/qjmed/hcg049

Source DB:  PubMed          Journal:  QJM        ISSN： 1460-2393


× No keyword cloud information.
  10 in total

1.  Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes.

Authors:  Xiaodan Zhang; William S Harmsen; Teresa A Mettler; W Ray Kim; Rosebud O Roberts; Terry M Therneau; Lewis R Roberts; Roongruedee Chaiteerakij
Journal:  Hepatology       Date:  2014-07-31       Impact factor: 17.425

Review 2.  Current Concepts in Diabetes Mellitus and Chronic Liver Disease: Clinical Outcomes, Hepatitis C Virus Association, and Therapy.

Authors:  Diego García-Compeán; José Alberto González-González; Fernando Javier Lavalle-González; Emmanuel Irineo González-Moreno; Jesús Zacarías Villarreal-Pérez; Héctor J Maldonado-Garza
Journal:  Dig Dis Sci       Date:  2016-02       Impact factor: 3.199

Review 3.  Metformin and metabolic diseases: a focus on hepatic aspects.

Authors:  Juan Zheng; Shih-Lung Woo; Xiang Hu; Rachel Botchlett; Lulu Chen; Yuqing Huo; Chaodong Wu
Journal:  Front Med       Date:  2015-02-12       Impact factor: 4.592

Review 4.  An Approach to the Management of Diabetes Mellitus in Cirrhosis: A Primer for the Hepatologist.

Authors:  Pankaj Puri; Narendra Kotwal
Journal:  J Clin Exp Hepatol       Date:  2021-09-16

5.  Metformin and the Development of Asthma in Patients with Type 2 Diabetes.

Authors:  Fu-Shun Yen; Chih-Cheng Hsu; Ying-Hsiu Shih; Wei-Lin Pan; James Cheng-Chung Wei; Chii-Min Hwu
Journal:  Int J Environ Res Public Health       Date:  2022-07-05       Impact factor: 4.614

6.  The Association between Metformin Therapy and Lactic Acidosis.

Authors:  Isabelle H S Kuan; Ruth L Savage; Stephen B Duffull; Robert J Walker; Daniel F B Wright
Journal:  Drug Saf       Date:  2019-12       Impact factor: 5.606

7.  GLP-1: target for a new class of antidiabetic agents?

Authors:  C Mark B Edwards
Journal:  J R Soc Med       Date:  2004-06       Impact factor: 18.000

8.  Epidemiology of lactic acidosis in type 2 diabetes patients with metformin in Japan.

Authors:  Chia-Hsien Chang; Motonobu Sakaguchi; Paul Dolin
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-05-25       Impact factor: 2.890

Review 9.  Osmolar-gap in the setting of metformin-associated lactic acidosis: Case report and a literature review highlighting an apparently unusual association.

Authors:  Mohamed Nabil Elshafei; Mohammed Alamin; Mouhand F H Mohamed
Journal:  Medicine (Baltimore)       Date:  2020-10-09       Impact factor: 1.817

10.  Metformin use and cirrhotic decompensation in patients with type 2 diabetes and liver cirrhosis.

Authors:  Fu-Shun Yen; Yi-Hsiang Huang; Ming-Chih Hou; Chii-Min Hwu; Yu-Ru Lo; Shyi-Jang Shin; Chih-Cheng Hsu
Journal:  Br J Clin Pharmacol       Date:  2021-07-22       Impact factor: 3.716
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.